-+ 0.00%
-+ 0.00%
-+ 0.00%

858 THERAPEUTICS ANNOUNCES FDA FAST TRACK DESIGNATION FOR PARG INHIBITOR ETX-19477 FOR THE TREATMENT OF PATIENTS WITH BRCA-MUTATED, HR+/HER2- UNRESECTABLE OR METASTATIC BREAST CANCER

Reuters·08/18/2026 12:02:54

Please log in to view news